High-performance liquid chromatographic determination and pharmacokinetic study of cefepime in goat plasma and milk after pre-column derivatization with Hg(I)

被引:13
作者
El-Rabbat, Newel A. [2 ]
Abdel-Wadood, Hanaa M. [2 ]
Sayed, Mohammed [3 ]
Mousa, Heba S. [1 ]
机构
[1] Assiut Univ, Drug Res Ctr, Assiut 71526, Egypt
[2] Assiut Univ, Dept Pharmaceut Analyt Chem, Fac Pharm, Assiut 71526, Egypt
[3] Assiut Univ, Dept Food Hyg, Fac Vet Med, Assiut 71526, Egypt
关键词
Cefepime; Goat milk; Goat plasma; HPLC; Pharmacokinetics; OUTER-MEMBRANE PERMEABILITY; DIRECT SAMPLE INJECTION; CEREBROSPINAL-FLUID; HUMAN URINE; 4TH-GENERATION CEPHALOSPORIN; MERCURY-ELECTRODE; BETA-LACTAMS; HUMAN SERUM; BMY-28142; STABILITY;
D O I
10.1002/jssc.201000294
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A highly sensitive and selective H PLC method with UV detection was developed for the determination of cefepime in goat plasma and milk. The proposed method was based on the complexation of cefepime with Hg(I) ions that imparts the high selectivity of the proposed method with enhancement of the sensitivity which enabled the analysis of cefepime in complex matrices such as plasma and milk. Detection was performed at 263 nm, using cefuroxime sodium as an internal standard. Chromatographic separation of cefepime and the internal standard was achieved with Aqua RP-C-18 column using methanol/triethylamine-acetate buffer, pH 3.5 (18:82, v/v) as mobile phase at a flow rate of 1 mL/min. Linear detector responses were observed spanning the range of 1.3-20 mu g/mL. The LOD for standard cefepime was 0.43 mu g/mL, whereas the LOD for cefepime in goat plasma was 0.84 mu g/mL and the corresponding value in goat milk was 1.1 mu g/mL. No interference from endogenous substances in plasma and milk was observed. The developed HPLC method has been successfully applied for the pharmacokinetic study of cefepime in goat plasma and milk, for the first time, after a single intramuscular injection of 50 mg cefepime/kg body weight.
引用
收藏
页码:2599 / 2609
页数:11
相关论文
共 52 条
[1]  
*AM PHARM ASS, 2008, US PHARM 31 NF 26, P813
[2]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS OF BMY-28142 IN PLASMA AND URINE [J].
BARBHAIYA, RH ;
FORGUE, ST ;
SHYU, WC ;
PAPP, EA ;
PITTMAN, KA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :55-59
[3]   SAFETY, TOLERANCE, AND PHARMACOKINETIC EVALUATION OF CEFEPIME AFTER ADMINISTRATION OF SINGLE INTRAVENOUS DOSES [J].
BARBHAIYA, RH ;
FORGUE, ST ;
GLEASON, CR ;
KNUPP, CA ;
PITTMAN, KA ;
WEIDLER, DJ ;
MARTIN, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :1118-1122
[4]   SAFETY, TOLERANCE, AND PHARMACOKINETICS OF CEFEPIME ADMINISTERED INTRAMUSCULARLY TO HEALTHY-SUBJECTS [J].
BARBHAIYA, RH ;
KNUPP, CA ;
TENNEY, J ;
MARTIN, RR ;
WEIDLER, DJ ;
PITTMAN, KA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (10) :900-910
[5]   NOVEL METHOD FOR MEASUREMENT OF OUTER-MEMBRANE PERMEABILITY TO NEW BETA-LACTAMS IN INTACT ENTEROBACTER-CLOACAE CELLS [J].
BELLIDO, F ;
PECHERE, JC ;
HANCOCK, REW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) :68-72
[6]   Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction [J].
Breilh, D ;
Lavallee, C ;
Fratta, A ;
Ducint, D ;
Cony-Makhoul, P ;
Saux, MC .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 734 (01) :121-127
[7]   The novel sensitive and high throughput determination of cefepime in mouse plasma by SCX-LC/MS/MS method following off-line μElution 96-well solid-phase extraction to support systemic antibiotic programs [J].
Bu, Wei ;
Sexton, Holly ;
Fan, Xiaoqing ;
Torres, Patricia ;
Houston, Paul ;
Heyman, Irwin ;
Liu, Liang .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (19) :1623-1628
[8]   Pitfalls in cefepime titration from human plasma: Plasma- and temperature-related drug degradation in vitro [J].
Bugnon, D ;
Giannoni, E ;
Majcherczyk, P ;
Glauser, MP ;
Moreillon, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3654-3656
[9]  
Calahorra B, 1999, BIOMED CHROMATOGR, V13, P272, DOI 10.1002/(SICI)1099-0801(199906)13:4<272::AID-BMC842>3.0.CO
[10]  
2-0